Within Our Reach - Logo

Grant Recipients

Through the Within Our Reach campaign, the REF is committed to funding innovative RA research that is not being done elsewhere, which will impact medical breakthroughs in RA and other rheumatic diseases. Below is the complete list of grant recipients funded through the campaign to date. These notable scientists—and the work they are performing—are integral in our quest to find a cure for RA.

Second-round Grant Recipients

Innovative Basic Research

Paul Ryan Thompson, PhD
University of South Carolina
Inhibition of PAD Function as a Novel Treatment Strategy for Rheumatoid Arthritis

Gregg J. Silverman, MD
The University of California, San Diego
Natural Antibody Treatment of Inflammatory Arthritis

Ellen M. Gravallese, MD
University of Massachusetts Medical School
Role of sFRP1 and WNT Signaling in Formation and Repair of Erosions in RA

Michael B. Brenner, MD
Brigham and Women's Hospital
How FLS Mediate Cadherin-11 Dependent Inflammation in RA

Xu Feng, PhD
University of Alabama at Birmingham
In vivo Validation of Novel Therapeutic Targets for Arthritic Bone Erosion

Song Guo Zheng, MD
Keck School of Medicine at the University of Southern California
Generation of Collagen-specific CD4+Foxp3+regulatory T cells Ex-vivoas an Adoptive Immunotherapy for Rheumatoid Arthritis

Richard M. Pope, MD
Northwestern University Feinberg School of Medicine
Endogenous Toll-like Receptor Ligands in Rheumatoid Arthritis

Shiva Shahrara, PhD
Northwestern University Feinberg School of Medicine
The Role of IL-17 in the Pathogenesis of Rheumatoid Arthritis

Steven Reyburn Goldring, MD
Hospital for Special Surgery
Bone Matrix-Induced Osteoclast Genes: Identification of Novel Targets for RA

Translational Research

Larry W. Moreland, MD
University of Pittsburgh
Multi-cytokine Profiling and Correlates with Outcome Measures and Treatment Responses in Patients with Early Rheumatoid Arthritis

Peter K. Gregersen, MD
Feinstein Institute for Medical Research
Cross Racial Strategies for Gene Identification in Rheumatoid Arthritis

William F. C. Rigby, MD
Dartmouth College
CD154 CA Repeat Polymorphisms and RA Pathogenesis

Carl Grunfeld, MD, PhD
University of California, San Francisco
Novel Cardiovascular Disease Risk Factors in Patients with Rheumatoid Arthritis

Robert M. Plenge, MD, PhD
Brigham and Women's Hospital
Genome-wide Association Study of Response to Anti-TNF Therapy in Rheumatoid Arthritis

Clinical Practice

Kenneth G. Saag, MD, MSc
University of Alabama at Birmingham
Improving Bone Health Among RA Patients on Chronic Glucocorticoids

First-round Grant Recipients

Innovative Basic Research

Paul Anderson, MD, PhD
K. Frank Austen Professor of Medicine
Brigham and Women's Hospital
Post-transcriptional Regulation of TNF alpha Production

Robert H. Carter, MD
Professor of Medicine and Microbiology
Director, Div. Clinical Immunology & Rheumatology
University of Alabama at Birmingham
Autoantigen-specific B cells in Rheumatoid Arthritis

Gary S. Firestein, MD
Professor of Medicine
Chief, Div. of Rheumatology, Allergy and Immunology
Director, UCSD Clinical Investigation Institute
University of California - San Diego, School of Medicine
Neural Regulation of Synovial Inflammation

Richard A. Flavell, PhD, FRS
Sterling Professor and Chairman
Investigator, Howard Hughes Medical Institute
Yale University School of Medicine
Regulation of T cell Function in Collagen-induced Arthritis by IL-10

Gary Gilkeson, MD
Professor of Medicine and Vice Chair for Research
Medical University of South Carolina
Role of Sphingosine Kinase I in Inflammatory Arthritis

Joseph Holoshitz, MD
Associate Professor of Internal Medicine
University of Michigan - Ann Arbor
Functional Characterization of the Rheumatoid Arthritis Shared Epitope Binding Receptor

Elizabeth D. Mellins, MD
Associate Professor
Stanford University School of Medicine
MHC Association in Rheumatoid Arthritis: A Novel Hypothesis

John D. Mountz, MD, PhD
Professor, Department of Medicine
University of Alabama at Birmingham
Novel IL-17 Induced Germinal Center Formation and Arthritis-inducing Autoantibodies

Translational Research

S. Louis Bridges, Jr., MD, PhD
Associate Professor, Departments of Medicine and Microbiology
University of Alabama at Birmingham
Genetics and Ethic Differences in C-Reactive Protein as a Biomarker of Radiographic Severity in Rheumatoid Arthritis

David M. Lee, MD, PhD
Assistant Professor of Medicine
Brigham and Women's Hospital
IgG Glycosylation and Rheumatoid Arthritis

Antony Rosen, MD
Mary Betty Stevens Professor of Medicine
Professor of Cell Biology and Pathology
Director, Division of Rheumatology
Johns Hopkins University School of Medicine
Anti-PADI4 Immune Responses in Rheumatoid Arthritis: Markers of Disease Propagation

Cornelia M. Weyand, MD, PhD
David Lowance Professor of Medicine
Director, Lowance Center for Human Immunology
Emory University
Defects of Hematopoietic Stem Cell Function in Rheumatoid Arthritis

Clinical Practice

Joan M. Bathon, MD
Professor of Medicine
Johns Hopkins Arthritis Center
Rheumatoid Arthritis and Body Composition

Harold E. Paulus, MD
Professor Emeritus
University of California - Los Angeles
Joint MRI to Validate Clinical Remission Criteria in Early Rheumatoid Arthritis

Edward Yelin, PhD
Professor of Medicine and Health Policy
University of California - San Francisco
Disparities in Utilization and Outcomes in Rheumatoid Arthritis

 

 

 

 

Home Contact Us Learn About WOR Research Invest in the Research Learn About RA

Keep me Informed